Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,291,488
-
Share change
-
+668,515
-
Total reported value
-
$2,052,441,707
-
Put/Call ratio
-
89%
-
Price per share
-
$58.17
-
Number of holders
-
208
-
Value change
-
+$22,212,212
-
Number of buys
-
106
-
Number of sells
-
133
Institutional Holders of GENOMIC HEALTH INC - COM (GHDX) as of Q2 2019
As of 30 Jun 2019,
GENOMIC HEALTH INC - COM (GHDX) was held by
208 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,291,488 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., STATE STREET CORP, ACADIAN ASSET MANAGEMENT LLC, Man Group plc, DEUTSCHE BANK AG\, MILLENNIUM MANAGEMENT LLC, and GOLDMAN SACHS GROUP INC.
This page lists
208
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.